The burden of skin disease in the United States
The burden of skin disease in the United States
复制标题
DOI：
10.1016/j.jaad.2016.12.043
复制
发表时间：
2017-05-01
影响因子：
13.8
通讯作者：
Moyano, Jose V.
中科院分区：
文献类型：
--
作者：
Lim, Henry W.;Collins, Scott A. B.;Moyano, Jose V.
自2006年美国国家皮肤病负担报告发布以来，皮肤病学和美国医疗保健系统的实践发生了重大变化。这些因素包括新的治疗方式的发展，药物成本的显着增加，日益复杂的付款规则和法规以及美国人口的老龄化。认识到需要最新的数据来告知研究人员，政策制定者，公共利益相关者和医疗保健提供者皮肤病对患者和美国社会的影响，美国皮肤病学会发布了一份新的国家皮肤病负担报告。该报告使用来自私人和政府保险提供商的2013年索赔数据，分析了美国人口中24种皮肤病类别的患病率，成本和死亡率。在这3篇文章的第一篇中，所提供的数据表明，2013年有近8500万美国人因至少1种皮肤病而接受医生治疗。这导致估计直接医疗保健成本为750亿美元，间接机会损失成本为110亿美元。此外，在24种皮肤病类别中，有一半出现死亡。
Since the publication of the last US national burden of skin disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of skin disease on patients and US society, the American Academy of Dermatology produced a new national burden of skin disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 skin disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 skin disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 skin disease categories.